Sang‐Young Ryu

665 total citations
21 papers, 440 citations indexed

About

Sang‐Young Ryu is a scholar working on Obstetrics and Gynecology, Surgery and Oncology. According to data from OpenAlex, Sang‐Young Ryu has authored 21 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Sang‐Young Ryu's work include Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (7 papers) and Colorectal and Anal Carcinomas (3 papers). Sang‐Young Ryu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (7 papers) and Colorectal and Anal Carcinomas (3 papers). Sang‐Young Ryu collaborates with scholars based in South Korea, China and Taiwan. Sang‐Young Ryu's co-authors include Moon‐Hong Kim, Kyunghee Lee, Sang-Il Park, Chul-Koo Cho, Kidong Kim, Tae Hun Kim, Byung‐Ho Nam, Jae‐Weon Kim, Soon‐Beom Kang and Kyoung‐Hee Lee and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

Sang‐Young Ryu

20 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sang‐Young Ryu South Korea 10 280 168 141 117 106 21 440
Lucía González‐Cortijo Spain 11 192 0.7× 179 1.1× 59 0.4× 94 0.8× 108 1.0× 26 434
Elke E.M. Peters Netherlands 9 452 1.6× 354 2.1× 116 0.8× 95 0.8× 95 0.9× 15 566
Frédéric Kridelka Belgium 10 195 0.7× 98 0.6× 96 0.7× 94 0.8× 37 0.3× 34 324
Eleonora B. van Dorst Netherlands 6 275 1.0× 88 0.5× 275 2.0× 218 1.9× 60 0.6× 8 465
Giuseppe Laurelli Italy 11 377 1.3× 289 1.7× 66 0.5× 89 0.8× 68 0.6× 18 523
Jaroslav Klát Czechia 12 379 1.4× 195 1.2× 240 1.7× 99 0.8× 143 1.3× 51 508
Liat Hogen Canada 11 274 1.0× 302 1.8× 94 0.7× 82 0.7× 81 0.8× 36 428
Pierre Lèguevaque France 11 274 1.0× 184 1.1× 109 0.8× 151 1.3× 47 0.4× 30 394
Astrid Baalbergen Netherlands 14 312 1.1× 212 1.3× 240 1.7× 176 1.5× 113 1.1× 24 601
Sherif Elsherif United States 11 81 0.3× 78 0.5× 63 0.4× 74 0.6× 85 0.8× 33 345

Countries citing papers authored by Sang‐Young Ryu

Since Specialization
Citations

This map shows the geographic impact of Sang‐Young Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Young Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Young Ryu more than expected).

Fields of papers citing papers by Sang‐Young Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Young Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Young Ryu. The network helps show where Sang‐Young Ryu may publish in the future.

Co-authorship network of co-authors of Sang‐Young Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Young Ryu. A scholar is included among the top collaborators of Sang‐Young Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Young Ryu. Sang‐Young Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wu, Lingying, Peng‐Hui Wang, Chih‐Long Chang, et al.. (2021). AdvanTIG-202: A phase 2 study investigating anti-TIGIT monoclonal antibody ociperlimab plus anti-PD-1 monoclonal antibody tislelizumab in patients with previously treated recurrent or metastatic cervical cancer.. Journal of Clinical Oncology. 39(15_suppl). TPS5595–TPS5595. 7 indexed citations
4.
Lee, Jina, Hee Jung Jung, Sang‐Young Ryu, et al.. (2020). An extremely rare elderly case of proximal epithelioid sarcoma of the vulva: case report with a review of literatures. Obstetrics & Gynecology Science. 63(5). 670–674. 4 indexed citations
5.
6.
Kim, Tae Hun, et al.. (2017). Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(5). 1124–1131. 50 indexed citations
7.
Jung, Nam-Chul, Jun‐Ho Lee, Jie Song, et al.. (2015). Tolerogenic dendritic cells show gene expression profiles that are different from those of immunogenic dendritic cells in DBA/1 mice. Autoimmunity. 49(2). 90–101. 8 indexed citations
8.
Kim, Mi‐Hyoung, Jiyeon Ahn, Seon Young Nam, et al.. (2015). Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. International Journal of Radiation Biology. 91(10). 795–803. 27 indexed citations
9.
Kim, Kidong, et al.. (2012). Efficacy of Fibrin Sealant in Reducing Hemorrhage after a Loop Electrosurgical Excision Procedure. Gynecologic and Obstetric Investigation. 74(1). 1–5. 9 indexed citations
10.
Ryu, Sang‐Young, Kidong Kim, Sang-Il Park, et al.. (2011). Randomized Clinical Trial of Weekly vs. Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(4). e577–e581. 54 indexed citations
11.
Kim, Kidong, et al.. (2011). Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery. Journal of Gynecologic Oncology. 22(2). 140–140.
12.
Kim, Kidong, Soo Youn Cho, Sang-Il Park, et al.. (2011). Risk of Metastatic Ovarian Involvement in Nongynecologic Malignancie. International Journal of Gynecological Cancer. 22(1). 3–8. 5 indexed citations
13.
Kim, Kidong, et al.. (2011). Guideline adherence to chemotherapy administration safety standards: a survey on nurses in a single institute. Journal of Gynecologic Oncology. 22(1). 49–49. 2 indexed citations
14.
Ryu, Sang‐Young, Sang-Il Park, Byung‐Ho Nam, et al.. (2010). Is Adjuvant Chemoradiotherapy Overtreatment in Cervical Cancer Patients With Intermediate Risk Factors?. International Journal of Radiation Oncology*Biology*Physics. 79(3). 794–799. 53 indexed citations
15.
Ryu, Sang‐Young, Kidong Kim, Sang-Il Park, et al.. (2010). Detection of Recurrence by 18F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease. Journal of Korean Medical Science. 25(7). 1029–1029. 17 indexed citations
16.
Kim, Kidong, Min-Jeong Kim, Hyun Hoon Chung, et al.. (2009). Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer. Medical Hypotheses. 73(6). 1005–1007. 5 indexed citations
17.
18.
Lee, Hyo‐Pyo, Sang‐Soo Seo, Sang‐Young Ryu, et al.. (2008). Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer. Gynecologic Oncology. 109(3). 359–363. 19 indexed citations
19.
Kim, Kidong, et al.. (2008). Major clinical research advances in gynecologic cancer 2008. Journal of Gynecologic Oncology. 19(4). 209–209. 14 indexed citations
20.
Ryu, Sang‐Young, et al.. (2003). Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.. PubMed. 44(3). 347–52. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucía González‐Cortijo Breakdown of academic impact, for papers by Elke E.M. Peters Breakdown of academic impact, for papers by Frédéric Kridelka Breakdown of academic impact, for papers by Eleonora B. van Dorst Breakdown of academic impact, for papers by Giuseppe Laurelli Breakdown of academic impact, for papers by Jaroslav Klát Breakdown of academic impact, for papers by Liat Hogen Breakdown of academic impact, for papers by Pierre Lèguevaque Breakdown of academic impact, for papers by Astrid Baalbergen Breakdown of academic impact, for papers by Sherif Elsherif
Rankless by CCL
2026